Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 18% ± 2% | |
| epithelial cell | 6 studies | 25% ± 11% | |
| GABAergic neuron | 4 studies | 34% ± 16% | |
| glutamatergic neuron | 4 studies | 41% ± 17% | |
| astrocyte | 4 studies | 23% ± 6% | |
| oligodendrocyte | 4 studies | 27% ± 4% | |
| erythroblast | 3 studies | 22% ± 5% | |
| macrophage | 3 studies | 18% ± 1% | |
| interneuron | 3 studies | 39% ± 17% | |
| microglial cell | 3 studies | 19% ± 1% | |
| adipocyte | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 668.43 | 21 / 21 | 100% | 19.89 | 504 / 504 |
| liver | 100% | 836.99 | 226 / 226 | 100% | 15.89 | 406 / 406 |
| ovary | 100% | 682.36 | 180 / 180 | 100% | 13.46 | 430 / 430 |
| prostate | 100% | 755.86 | 245 / 245 | 100% | 20.06 | 502 / 502 |
| uterus | 100% | 655.69 | 170 / 170 | 100% | 18.02 | 459 / 459 |
| esophagus | 100% | 655.45 | 1444 / 1445 | 100% | 14.91 | 183 / 183 |
| breast | 100% | 813.22 | 459 / 459 | 100% | 22.42 | 1116 / 1118 |
| intestine | 100% | 766.43 | 966 / 966 | 100% | 17.75 | 526 / 527 |
| skin | 100% | 1010.75 | 1809 / 1809 | 100% | 20.25 | 471 / 472 |
| stomach | 100% | 620.50 | 358 / 359 | 100% | 16.42 | 286 / 286 |
| thymus | 100% | 616.27 | 652 / 653 | 100% | 9.71 | 603 / 605 |
| brain | 100% | 661.58 | 2630 / 2642 | 100% | 13.09 | 704 / 705 |
| lung | 99% | 672.63 | 573 / 578 | 100% | 17.02 | 1155 / 1155 |
| pancreas | 100% | 542.41 | 327 / 328 | 99% | 13.42 | 177 / 178 |
| kidney | 100% | 584.80 | 89 / 89 | 99% | 9.87 | 889 / 901 |
| adrenal gland | 100% | 1092.74 | 258 / 258 | 98% | 10.41 | 226 / 230 |
| adipose | 100% | 854.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 20.39 | 29 / 29 |
| spleen | 100% | 988.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.74 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.34 | 1 / 1 |
| muscle | 100% | 611.47 | 801 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 462.54 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 15.86 | 79 / 80 |
| heart | 97% | 407.79 | 831 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 625.55 | 759 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_2000210 | Biological process | positive regulation of anoikis |
| GO_2000811 | Biological process | negative regulation of anoikis |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| GO_0004045 | Molecular function | aminoacyl-tRNA hydrolase activity |
| Gene name | PTRH2 |
| Protein name | Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1) peptidyl-tRNA hydrolase (EC 3.1.1.29) |
| Synonyms | CGI-147 BIT1 PTH2 |
| Description | FUNCTION: The natural substrate for this enzyme may be peptidyl-tRNAs which drop off the ribosome during protein synthesis. .; FUNCTION: Promotes caspase-independent apoptosis by regulating the function of two transcriptional regulators, AES and TLE1. . FUNCTION: The natural substrate for this enzyme may be peptidyl-tRNAs which drop off the ribosome during protein synthesis. . |
| Accessions | ENST00000409433.2 Q9Y3E5 J3KQ48 ENST00000393038.3 ENST00000470557.2 |
